Trials / Completed
CompletedNCT03120169
Effects of Treadmill Versus Cycling Endurance Training in Patients With COPD
Effects of a Three Week Treadmill Versus Cycling Endurance Training on Balance, Gait Performance and Exercise Capacity in Patients With Chronic Obstructive Pulmonary Disease - a Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Schön Klinik Berchtesgadener Land · Academic / Other
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Aim of this study is to investigate the effects of treadmill versus cycling endurance training on Balance, gait performance and exercise capacity in patients with severe chronic obstructive pulmonary disease. Patients will be recruited during a 3-week inpatient pulmonary rehabilitation program and will be randomized into one of two intervention groups. Walking intensity in the treadmill group will be set at 80 percent of the average speed of the 6-minute walking test. The cycling group will exercise at an intensity of 60 percent according to an Initial incremental cycling test. Patients will perform 5 to 6 training sessions per week. The total exercise duration will be progressively increased from 10 to 30 minutes. Walking or cycling intensity will also be progressively increased if perceived exertion during exercise is rated below 3 on the modified 10-point Borg scale.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | treadmill endurance training | n = 15 patients with COPD. Walking intensity will be initially set at 80 percent of 6-minute Walking test Speed with progressive increase in Duration and intensity. |
| OTHER | cycling endurance training | n=15 patients with COPD. Cycling intensity will initially be set at 60 percent of Peak work rate with progressive increase in Duration and intensity |
Timeline
- Start date
- 2017-03-30
- Primary completion
- 2017-11-27
- Completion
- 2017-11-27
- First posted
- 2017-04-19
- Last updated
- 2018-02-15
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03120169. Inclusion in this directory is not an endorsement.